Nocebo effects, patient-clinician communication, and therapeutic outcomes

JAMA

Volumn 307, Issue 6, 2012, Pages 567-568

  Colloca, Luana ^a   Finniss, Damien ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; COMMUNICATION SKILL; DOCTOR PATIENT RELATION; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; NOCEBO EFFECT; PATIENT AUTONOMY; PATIENT EDUCATION; PLACEBO EFFECT; PRIORITY JOURNAL; SHAM PROCEDURE; SHORT SURVEY; TREATMENT OUTCOME; VERBAL COMMUNICATION;

EID: 84856772780     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.115     Document Type: Short Survey

References (8)

1. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010;375(9715):686-695.
2. Brody H, Miller FG. Lessons from recent research about the placebo effect: from art to science. JAMA. 2011;306(23):2612-2613.
3. Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain. 2008;136(1-2):211-218.
4. Rodriguez-Raecke R, Doganci B, Breimhorst M, et al. Insular cortex activity is associated with effects of negative expectation on nociceptive long-term habituation. J Neurosci. 2010;30(34):11363-11368.
5. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 2004;3(11):679-684. (Pubitemid 39370638)
6. Kaptchuk TJ, Stason WB, Davis RB, et al. Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ. 2006;332(7538):391- 397.
7. Varelmann D, Pancaro C, Cappiello EC, Camann WR. Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg. 2010;110(3):868-870.
8. Mondaini N, Gontero P, Giubilei G, et al. Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med. 2007;4(6):1708-1712. (Pubitemid 47616863)